The Bishop of Exeter received the following written answer on 23rd January 2023:
The Lord Bishop of Exeter asked His Majesty’s Government what assessment they have made of the cost effectiveness of Evusheld in the treatment of immuno-compromised persons with complex health needs against the cost of an admission to hospital, given the increase in COVID-19 hospital admissions and the pressure on the NHS.
Continue reading “Bishop of Exeter asks about cost effectiveness of treating immuno-compromised patients with Evusheld medication”
The Church of England in Parliament 
You must be logged in to post a comment.